A chronic myeloproliferative neoplasm associated with increased risk of thrombosis and bleeding, and disease progression to either myelofibrosis and/or acute leukemia. Caused by somatic mutations in JAK2 (Janus kinase), typically V617F.
Jun
22
2022
Jun
22
2022
A chronic myeloproliferative neoplasm associated with increased risk of thrombosis and bleeding, and disease progression to either myelofibrosis and/or acute leukemia. Caused by somatic mutations in JAK2 (Janus kinase), typically V617F.